Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Alpha-actinin–4 is a non-muscle isoform of the alpha-actinin family, encoded by the ACTN4 gene. It is a member of the spectrin superfamily and functions as an antiparallel homodimer that crosslinks filamentous actin (F-actin) in the cytoplasm. The protein contains an N-terminal actin-binding domain with calponin homology domains, a central rod domain for dimerization, and a C-terminal calmodulin-like domain with EF-hand motifs. Alpha-actinin–4 plays essential roles in organizing the actin cytoskeleton, maintaining cell shape, facilitating focal adhesion dynamics through interactions with integrins at the plasma membrane, and regulating cell motility. It is ubiquitously expressed in non-muscle cells but can also be found in neoplastic tissues. Mutations in alpha-actinin–4 are associated with autosomal dominant forms of kidney disease such as focal segmental glomerulosclerosis; these mutations often increase its affinity for F-actin or disrupt normal regulation by calcium ions[1][2][3][5]. In cancer biology, altered expression or function has been linked to increased metastatic potential due to changes in cellular adhesion and migration properties. No approved drugs are known to directly target alpha-actinin–4; it is not currently considered a direct therapeutic target such as receptors or enzymes but rather serves critical structural roles within cells[6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Alpha-actinin-4 (ACTN4).